FDA Inspection 1226827 — Xo Biologix
The FDA completed an inspection of Xo Biologix on Jan 5, 2024 in Austin, TX. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Biologics.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jan 5, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Austin, TX (United States)